Novartis Acquires Gene Therapy Company for $8.7B
The Swiss pharmaceuticals giant offered 88% above AveXis’s closing price on Friday.
Tag Archives: NVS
GSK Shares Surge on $13B Buyout Deal Struck With Novartis
The British pharmaceutical giant expects its move to buy Novartis out of their consumer healthcare joint venture to immediately boost earnings.
The Top 5 Johnson & Johnson Shareholders (JNJ)
Learn about the origins of Johnson & Johnson and the health care conglomerate's five largest shareholders.
Amazon in Exploratory Talks with Generic-Drug Makers: Report
One source says the company is exploring whether to enter the drug purchasing market.
Gilead Rally Isn’t Fully Warranted: Morgan Stanley
Biotech stocks jump this week on news of Gilead's $12 billion acquisition of Kite Pharma Inc.
Drugmakers May Lose $390B In Sales Over 5 Years
Drug stocks may be hurt by slashed sales and earnings as prices soften
Three Hot Junior Biotech Plays
Major biotech funds are struggling after a series of high-profile drug pricing scandals, but that hasn't stopped the flow of junior biotech winners. (CNAT)
Novartis Licenses ECF843 Eye Drops From Lubris
Novartis licensed ECF843 eye drops outside Europe from Lubris LLC.
Pfizer’s Ibrance Gets FDA Approval for Breast Cancer
Ibrance got FDA approval and an expanded Indication to treat metastatic breast cancer.
Novartis’ Lung Cancer Drug Combo Gets EU Nod
Novartis has secured approval from the European Commission for its lung cancer drug combo.